Malaria chemotherapy has been well reviewed(1-3)). Malarial parasites
gaining resistance is the major problem in the treatment of the diseas
e. Some strains are resistant not only to chloroquine but also to amod
iaquine. Few new drugs are available or foreseen for the near future(4
,5)). The principal metabolite of cinchona alkaloids appears to be oxi
dized at C-2. This may result in a loss of activity. Pinder and Burger
suggested that a trifluoromethyl group will prevent this oxidation(6)
). So -4-(4-hydroxy-3-pyrrolidinomethylanilino)quinoline (1) was synth
esized as a potential biocide (Scheme 1).